BioQuant Inc., Metra deal

BioQuant (Ann Arbor, Mich.) will evaluate the utility of Metra's Pyrilinks technology in measuring pyridinium crosslinks excreted through perspiration collected by BioQuant's skin patch technology. The objective is to create an assay in which the patch would be used to collect sweat over a 3-to-5 day period, after which the user would mail the patch to BioQuant's laboratory for analysis of Metra's markers of bone resorption. ...